SERA Stock Analysis: Buy, Sell, or Hold?
SERA - Sera Prognostics, Inc. Class A Common Stock
$1.72
-0.07 (-3.91%)
▼
5d:
-8.51%
30d:
-26.81%
90d:
-35.09%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When SERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SERA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SERA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SERA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SERA is currently trading at $1.72, which is considered oversold relative to its 30-day fair value range of $1.79 to $2.18.
Technical Outlook: Technically, SERA is in a strong downtrend. Immediate support is located at $1.56, while resistance sits at $2.11. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: SERA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+190.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SERA is in a strong downtrend. Immediate support is located at $1.56, while resistance sits at $2.11. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: SERA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+190.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.79 -
$2.18
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 190.7% below Wall St target ($5.00)
- CAUTION: 5-day price weakness (-8.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.79 -
$2.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.56
Resistance Level
$2.11
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.51
Wall Street Target
$5.00
(+190.7%)
Revenue Growth (YoY)
-63.2%
Share & Embed Analysis
Last updated: May 18, 2026 7:09 AM ET
Data refreshes hourly during market hours. Next update: 8:09 AM
Data refreshes hourly during market hours. Next update: 8:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Austin Aerts
SELL
1019 shares
2026-03-11
Zhenya Lindgardt
SELL
2973 shares
2026-03-11
Robert Gardner Harrison
SELL
716 shares
2026-03-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
